1. Home
  2. MIGI vs RNXT Comparison

MIGI vs RNXT Comparison

Compare MIGI & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mawson Infrastructure Group Inc.

MIGI

Mawson Infrastructure Group Inc.

HOLD

Current Price

$4.76

Market Cap

33.6M

Sector

Finance

ML Signal

HOLD

Logo RenovoRx Inc.

RNXT

RenovoRx Inc.

HOLD

Current Price

$0.89

Market Cap

37.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MIGI
RNXT
Founded
2012
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.6M
37.0M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
MIGI
RNXT
Price
$4.76
$0.89
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
N/A
$8.25
AVG Volume (30 Days)
167.5K
311.0K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
20.00
EPS
N/A
N/A
Revenue
$39,754,085.00
$1,123,000.00
Revenue This Year
N/A
$194.66
Revenue Next Year
N/A
$279.78
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2511.63
52 Week Low
$0.28
$0.70
52 Week High
$15.80
$1.45

Technical Indicators

Market Signals
Indicator
MIGI
RNXT
Relative Strength Index (RSI) 49.42 48.40
Support Level $3.95 $0.89
Resistance Level $5.20 $1.07
Average True Range (ATR) 1.19 0.07
MACD -0.15 0.01
Stochastic Oscillator 23.12 54.09

Price Performance

Historical Comparison
MIGI
RNXT

About MIGI Mawson Infrastructure Group Inc.

Mawson Infrastructure Group Inc is focused on digital infrastructure platforms. It designs, builds and operates next-generation digital infrastructure platforms for enterprise customers and for its own purposes. The company provides services spanning AI, HPC, digital assets including Bitcoin mining, and other intensive compute applications. The company delivers both self-mining operations and colocation services to enterprise customers with a vertically integrated infrastructure model built for scalability and efficiency. The company also has an energy management business, which utilizes software and analysis, to generate revenue by participating in energy management programs. It operates as one energy management and digital asset mining segment.

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Share on Social Networks: